Results 131 to 140 of about 5,627,179 (327)
American Journal of Hematology, Volume 101, Issue 2, Page 304-310, February 2026.ABSTRACT Chronic kidney disease (CKD) is common and a major contributor to increased morbidity and early mortality in people with sickle cell anemia (SCA). Urine albumin‐to‐creatinine ratio (uACR) is recommended to identify patients with SCA‐related CKD but its utility in predicting long‐term kidney dysfunction remains unclear in this patient ...
Pablo Bartolucci +12 more
wiley +1 more source
The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease. [PDF]
, 2020 Sickle cell disease (SCD) is an extremely heterogeneous disease that has been associated with global morbidity and early mortality. More effective and inexpensive therapies are needed.
Ballas, Samir K
core +1 more source
British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 568-578, February 2026.Aims In haematopoietic cell transplantation (HCT), neutropenia resulting from myelosuppression is an expected endpoint following busulfan‐based conditioning. However, if prolonged, neutropenia can lead to complications like serious infection and death.
Beth Apsel Winger +6 more
wiley +1 more source
The history of beta-thalassemia in Turkey
The Turkish Journal of Pediatrics, 1991 The first two patients with beta-thalassemia major in Turkey, were reported in 1941. However, the importance of beta-thalassemia as a health problem was brought to the attention of physicians only after 1950.
M Aksoy
doaj
Digenic Functional B12 and Folate Defect Mimicking Myelodysplasia
Clinical Case Reports, Volume 14, Issue 2, February 2026.Proposed mechanistic model of mutation‐related outcomes. ABSTRACT A digenic defect involving CUBN and MTHFR produced functional B12/folate deficiency in a patient with pancytopenia and neurological signs, mimicking myelodysplasia. Genetic and metabolic screening revealed elevated methylmalonic acid/homocysteine, with rapid remission post‐parenteral B12.
Thomas Cluzeau +3 more
wiley +1 more source
Journal of Tehran University Heart Center, 2015 Background: Heart disease is the main cause of mortality and morbidity in patients with beta thalassemia, rendering its early diagnosis vital. We studied and compared echocardiographic findings in patients with beta thalassemia major, patients with beta ...
Noormohammad Noori +5 more
doaj
Evalution of HbA2 In Minor β Thalassemia Carriers Reffered to Kerman Special Disease Center [PDF]
Journal of Kerman University of Medical Sciences, 2003 Increased HbA2 is a characteristic finding in minor beta thalassemia. Minor β-thalassemia is a heterozygote form of β-thalassemia that carries thalassemia genes but does not cause thalassemia disease.
M Atapour +3 more
doaj
B- THALASSEMIA MAJOR IN RAMADI
مجلة كلية الطب, 2005 Background:
Zeina H Al Shemmari +2 more
doaj +1 more source
Amenorrhea in β‐Homozygous Thalassemia Major
Annals of the New York Academy of Sciences, 1997 Hemolytic anemias, and, in particular, beta-homozygous thalassemia, derange all vital organs. A shift of the survival curve to the right has been achieved, thanks to the intensive programs of blood transfusion; iron chelation; infectious control; and, most recently, bone marrow transplantation.
Tolis, G., Papandreou, A., Karydis, I.
openaire +3 more sources